Navigation Links
Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results
Date:11/15/2010

s force and achieved its 2010 goal of hiring 52 sales representatives.  The Company anticipates continued revenue growth acceleration as both its expanding direct and indirect sales efforts impact the market.  

The Company reported a net loss of $(9.0) million or $(0.26) per basic share for the third quarter of 2010, which included a non cash warrant derivative liability charge of $6.7 million due to the strong appreciation in the stock price to $7.45 during the quarter. This compares to $(1.9) million or $(0.09) per basic share for the third quarter 2009 and a net loss of $(2.0) million or $(0.07) per basic share for the second quarter 2010.  During the final month of third quarter 2010, Bacterin achieved EBITDA breakeven.  The Company expects to be EBITDA profitable for the fourth quarter of 2010 going forward.

For the three months ended September 30, 2010, Bacterin's gross profit on revenue totaled $3.5 million, yielding a gross margin of 83 percent, compared to 30 percent for the three months ended September 30, 2009 and 84 percent for the second quarter of 2010.  The material year over year gross margin increase was due to a one time inventory adjustment of approximately $669,000 which resulted in an increase in cost of tissue sales recorded in the third quarter of 2009.   Given the company's current mix of business, Bacterin expects gross margins over 80 percent for the foreseeable future.

Operating expenses during the third quarter of 2010 totaled $5.6 million, an increase of approximately $3.4 million (159%) over the third quarter of 2009 and an increase of approximately $1.6 million (41%) over the second quarter of 2010.  A significant portion of the expense increase, approximately $2.0 million year-over-year and $636,000 quarter-over-quarter, was attributed to costs associated with the implementation of a direct sales force.  General and administrative costs also increased approximately $672,000
'/>"/>

SOURCE Bacterin International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Bacterin International Completes $3 Million Private Placement
2. Bacterin International Introduces OsteoSelect(R) DBM Putty
3. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
4. Bacterin International Holdings, Inc. Completes Merger and $7.5 Million Raise
5. Bacterin International Holdings, Inc. to Present at the 6th Annual Fall Growth Stock Conference Hosted by Security Research Associates, Inc.
6. Bacterin International to Present at Singular Research 5th Annual Best of the Uncovereds Conference
7. Bacterin International Holdings, Inc. Schedules Conference Call to Present Third Quarter 2010 Financial Results
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
11. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... The issue: Mylan Pharmaceuticals ULC Canada, in consultation with Health ... 0.4 mg/metered dose due to the product missing the "dip ... A missing "dip tube" could pose a potential problem ... may lead patients to believe they are receiving the nitroglycerin, ... receiving nitroglycerin could place them at risk for either a ...
(Date:9/19/2014)... , Sept. 19, 2014 Medical science ... relationships with key opinion leaders (KOLs) who can ... Despite the critical nature of the MSL function, ... including altering the landscape for creating and maintaining ... to research, the oversight responsibility for the MSL ...
(Date:9/19/2014)... , Sept. 19, 2014 Harwood Feffer LLP ... board of directors of PDL BioPharma, Inc. ("PDL" or ... the board has breached its fiduciary duties to shareholders ... September 16, 2014, the Company disclosed: "On September 11, ... accounting firm, Ernst & Young LLP ("EY"), that it ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
... 2011 ,   EP ... of the Year Award at the European Mediscience,Awards, sponsored ... award, which honours clear and concise commentary in the,pharma ... research houses or specialist websites dedicated to,providing sharp, perceptive ...
... 24, 2011 New Phase 2 clinical trial data ... of Medicine show that patients with moderate to ... bardoxolone methyl for 52 weeks experienced a sustained improvement ... by estimated glomerular filtration rate (eGFR). The data were ...
Cached Medicine Technology:EP Vantage Wins Commentator of the Year Award at European Mediscience Awards 2011 2EP Vantage Wins Commentator of the Year Award at European Mediscience Awards 2011 3New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes 2New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes 3New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes 4
(Date:9/21/2014)... Colorado (PRWEB) September 21, 2014 High ... ten teams of disabled and able-bodied athletes rafted the ... completed a ropes course in pursuit of outdoor adventure. ... from national non-profit World T.E.A.M. Sports, disabilities proved to ... who successfully completed the three stage event. , Each ...
(Date:9/21/2014)... York, NY (PRWEB) September 21, 2014 ... http://www.thegranuflolawsuit.com/ ) have been added over the past ... claims that allege serious cardiovascular injuries caused by ... A Case List updated on September 15th shows ... in the U.S. District Court, District of Massachusetts. ...
(Date:9/21/2014)... An experienced review website in the global market, ... and announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and ... There has been a boom in websites in recent ... increase in the number of web hosting companies that ... prices. VPS (Virtual Private Server) is the method of ...
(Date:9/21/2014)... 21, 2014 “Cluster headaches are sometimes ... and difficult to resolve,” said Steve Young of Ew ... of a pain that is more intense.” , “It ... cluster headaches, or migraines, that medical research is pointing ... system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) is a ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 Recently, BambooIndustry.com, ... a special offer for its bamboo panels ( http://www.bambooindustry.com/products/bamboo-panel/ ... the market; all of them are available at discounted ... , The company’s discounted bamboo panels are ... made of quality materials. Each of them is finely ...
Breaking Medicine News(10 mins):Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2
... with the non-profit organization HopeLab to deliver innovative interventions ... young people with chronic illnesses . Their first joint ... and young adults with cancer by offering free of ... works. It gives young people with cancer a sense ...
... are more active and have less body fat than ... today at the 54th American College of Sports Medicine ... associated with higher levels of self-reported leisure-time physical activity ... weight, status, and neighborhood, environment, walkability, and income between ...
... lawmakers to set aside 30 billion dollars over five years ... proposal fell short of funds needed to battle the global ... would visit Africa in June to assess HIV/AIDS-fighting strategies in ... works and what does not in battling the deadly disease. ...
... holy city of Najaf on Friday after receiving treatment for ... of the most powerful parties in the parliament, spent nearly ... in the United States and treatment in Iran. ... there for a long time, after he finished his initial ...
... study has found that people can be encouraged to walk ... if they are given the right kind of help. ... the Scottish Physical Activity Research Collaboration (SPARColl), the study suggests ... of waysface to face advice or telephone support, using pedometers, ...
... found three new drugs that may help transform the ... thus giving hope for chronically infected patients. ,The ... Hiroyu Hatano, and Steven Deeks at San Francisco General ... new drugs are the HIV integrase inhibitors, R5 inhibitors, ...
Cached Medicine News:Health News:CIGNA HealthCare Teams With HopeLab to Help Blast Teen Cancer 2Health News:Dog Owners More Active, Leaner 2Health News:Bush Seeks Doubling of AIDS-fighting Funds 2Health News:Top Iraqi Shiite Leader Returns Home 2
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Stat Detection of Soluble Fibrin Monomer Complexes by the Hemagglutination Technique, 32 tests....
Batch Detection of Soluble Fibrin Monomer Complexes by the Hemagglutination Technique, 40 tests....
For use with catalog #0454....
Medicine Products: